Imipramine treatment of alcoholics with primary depression: A placebo-controlled clinical trial

Archives of General Psychiatry

Volumn 53, Issue 3, 1996, Pages 232-240

  McGrath, Patrick J ^a   Nunes, Edward V ^a   Stewart, Jonathan W ^a   Goldman, Deberah ^a   Agosti, Vito ^a   Ocepek Welikson, Katja ^a   Quitkin, Frederic M ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMIPRAMINE;

ADULT; ALCOHOLISM; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MALE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; ALCOHOL DRINKING; ALCOHOLICS ANONYMOUS; ALCOHOLISM; AMBULATORY CARE; DEPRESSIVE DISORDER; FEMALE; HUMANS; IMIPRAMINE; MALE; PLACEBOS; PROGNOSIS; TREATMENT OUTCOME;

EID: 0029867460     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.1996.01830030054009     Document Type: Article

References (54)

1. Institute of Medicine. Causes and Consequences of Alcohol Problems. Washington, DC: National Academy Press; 1987.
2. Weissman MM, Myers JK. Clinical depression in alcoholism. Am J Psychiatry. 1980,137 372-373
3. Boyd JH, Burke JD, Gruenberg E, Holzer CE, Rae DS, George LK, Karuo M, Stoltzman R, McEvoy L. Exclusion criteria of DSM-III: a study of cooccurrence of hierarchy-free syndromes. Arch Gen Psychiatry 1984;41:983-989
4. Heizer JE, Canino GJ, Hwu HG, Bland RC, Newman S, Yeh EK. Alcoholism: a cross-national comparison of population survey with the Diagnostic Interview Schedule. In: Rose RM, Barrett JE, eds. Alcoholism: Origins and Outcome. New York, NY: Raven Press; 1988:31-47.
5. Helzer JE, Pryzbeck TR. The co-occurrence of alcoholism and other psychiatric disorders in the general population and its impact on treatment. J Stud Alcohol. 1988;49:219-224.
6. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, Goodwin FK. Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiologic Catchment Area (ECA) Study. JAMA. 1990;264:2511-2518.
7. Rohde P, Lewinsohn PM, Seeley JR. Comorbidity of unipolar depression, II. comorbidity with other mental disorders in adolescents and adults J Abnorm Psychol. 1991;100 214-222
8. Merikangas KR, Gelernter CS. Comorbidity for alcoholism and depression. Psychiatr Clin North Am. 1990,13:613-632.
9. Coulehan JL, Zettler-Segal M, Block M, McClelland M, Schulberg HC Recognition of alcoholism and substance abuse in primary care patients. Arch intern Med 1987,147349-352
10. Schuckit MA Genetic and clinical implications of alcoholism and affective disorder. Am J Psychiatry 1986,143 140-147.
11. Meyer RE. Prospects for a rational pharmacotherapy of alcoholism. J Clin Psychiatry. 1989;50:403-412.
12. Cloninger CR, Reich T, Wetzel R Alcoholism and affective disorders familial association and genetic models. In: Goodwin DW, Erickson CK, eds. Alcoholism and Affective Disorders: Clinical, Genetic, and Biochemical Studies. New York, NY: SP Medical & Scientific Books; 1979:57-86.
13. Schuckit MA Genetic and clinical implications of alcoholism and affective disorder. Am J Psychiatry. 1986,143.140-147.
14. Finn PR, Kleinman I, Pihl RO. The lifetime prevalence of psychopathology in men with multigenerational family histories of alcoholism J Nerv Ment Dis. 1990;178:500-504.
15. Winokur G, Coryell W. Familial alcoholism in primary unipolar major depressive disorder. Am J Psychiatry. 1991;148.184-188
16. Ingraham LJ, Wender PH. Risk for affective disorder and alcohol and other drug abuse in the relatives of affectively ill adoptees. J Affect Disord. 1992; 26:45-52.
17. Kendler KS, Heath AC, Neale MC, Kessler RC, Eaves LJ. Alcoholism and major depression in women. Arch Gen Psychiatry 1993;50:690-698.
18. Schuckit MA, Winokur G. A short term follow-up of women alcoholics. Dis Nerv Sys. 1972;33:672-678.
19. Schuckit MA. The clinical implications of primary diagnostic groups among alcoholics. Arch Gen Psychiatry. 1985,42:1043-1049.
20. Brown SA, Schuckit MA. Changes in depression among abstinent alcoholics, J Stud Alcohol. 1988;49:412-417.
21. Coryell W, Endicottt J, Keller M. Major depression in a nonclinical sample. Arch Gen Psychiatry. 1992;49:117-125.
22. Mason BJ, Kocsis JH. Desipramine treatment of alcoholism. Psychopharm Bull 1991,27 155-161
23. Quitkin FM, Rifkin A, Kaplan J, Klein DF. Phobic anxiety syndrome complicated by drug dependence and addiction: a treatable form of drug abuse. Arch Gen Psychiatry. 1972;27:159-162.
24. Khantzian EJ. The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. Am J Psychiatry. 1985;142.1259-1264.
25. Powell BJ, Penick EC, Othmer E, Bingham SF, Rice AS Prevalence of additional psychiatric syndromes among male alcoholics J Clin Psychiatry 1982; 43:404-407
26. Hesselbrock M, Meyer RE, Keener JJ. Psychopathology in hospitalized alcoholics. Arch Gen Psychiatry. 1985;42:1050-1055.
27. O'Sullivan K. Depression and its treatment in alcoholics: a review Can J Psychiatry. 1984;29:379-384.
28. Shaw JA, Donley P, Morgan DW, Robinson JA. Treatment of depression in alcoholics. Am J Psychiatry 1975;132:641-644.
29. Ciraulo DA, Jaffe JH Tricyclic antidepressants in the treatment of depression associated with alcoholism. J Clin Psychopharm. 1981;1:146-150.
30. Liskow BI, Goodwin DW Pharmacological treatment of alcohol intoxication, withdrawal and dependence• a critical review. J Stud Alcohol 1987;48.356-370.
31. Nunes EV, McGrath PJ, Quitkin FM, Stewart JW, Harrison W, Tricamo E, Ocepete-Welikson K Imipramine treatment of alcoholism with comorbid depression Am J Psychiatry. 1993;150:963-965.
32. Cornelius J, Salloum IM, Cornelius MD, Perel JM, Thase ME, Ehler JG; Mann JJ. Fluoxetine trial in suicidal depressed alcoholics. Psychopharm Bull. 1993; 29:195-199.
33. Kranzler HR, Burleson JA, Korner P, Del Boca FK, Bohn MJ, Brown J, Liebowitz N. Placebo-controlled trial of fluoxeline as an adjunct to relapse prevention in alcoholics. Am J Psychiatry. 1995;152:391-397.
34. Spitzer RL, Williams JBW, Gibbon M, First MB The structured clinical interview for DSM-III-R (SCID), I: history, rationale, and description. Arch Gen Psychiatry 1992;49:624-629.
35. Nunes EV, Goehl L, Seracini A, Deliyannides D, Donovan S, Koenig T, Quitkin FM, Williams J. Evaluation of depression and panic disorder in methadone patients using a modification of the structured clinical interview for DSM III-R: test-retest reliability. Am J Addict. In press.
36. Stewart JW, Rabkin JG, Quitkin FM, McGrath PJ, Klein DF Atypical depression. In: Dunner DL, ed. Current Psychiatric Therapy. Philadelphia, Pa WB Saunders Co; 1992:215-220.
37. Guy W, ed. ECDEU Assessment Manual for Psychopharmacology, Revised Edition. Rockville, Md: National Institute of Mental Health; 1976 US Dept of Health, Education, and Welfare publication (ADM) 76-338.
38. Sobell MB, Malsto SA. Sobell LC, Cooper AM, Cooper TC, Sanders M. Developing a prototype for evaluating alcohol treatment effectiveness In: Sobell LC, Sobell MB, Ward E, eds. Evaluating Alcohol and Drug Abuse Treatment Effectiveness: Recent Advances. Elmstord, NY Pergamon Press Inc; 1980
39. Hamilton M. A rating scale for depression J Neurol Neurosurg Psychiatry. 1960;23:56-62.
40. Kapur BM, Israel Y. Alcohol dipstick: a rapid method for analysis of ethanol in body fluids. In: Chang NC, Chao HM, eds. Early Identification of Alcohol Abuse Rockville, Md: US Dept of Health and Human Services; 1985:1-30 Research Monograph No. 17.
41. Marlatt GA, Gordon JR. Relapse Prevention. New York, NY Guilford; 1985.
42. Cornfield J. A statistical problem arising from retrospective studies In: Neyman J. ed. Proceedings of the Third Berkeley Symposium on Mathematical Statistics and Probability. Berkeley, Calif: University of California Press, 1956;4.135-148.
43. Selzer M. The Michigan alcoholism screening test- the quest for a new diagnostic instrument. Am J Psychiatry. 1971,127-1653-1658.
44. Derogatis LR. SCL-90 Administration, Scoring, and Procedures Manual. Baltimore, Md: Clinical Psychiatry Research; 1977.
45. Montgomery HA, Miller WR, Tonigan JS. Does alcoholics anonymous involvement predict treatment outcome? J Subst Abuse Treat 1995,12:241-246.
46. Ouitkin FM, Stewart JW, McGrath PJ, Tricamio E, Rabkim JG, OcepeleWelikson K, Nunes E, Harrison W, Klein DF Columbia atypical depression a subgroup of depressives with better response to MAOI than to tricyclic anti-depressants or placebo. Br J Psychiatry. 1993;163(suppl 21):30-34.
47. Omalley SS, Jaffe AJ, Chang G, Schottenfeld RS, Meyer RE, Rounsaville B. Naltrexone and coping skills therapy for alcohol dependence: a controlled study. Arch Gen Psychiatry. 1992;49:894-898.
48. Volpicelli JR, Alterman AI, Hayashida M, O'Brien CP. Naltrexone in the treatment of alcohol dependence Arch Gen Psychiatry. 1992,49 876-880
49. Naranjo CA, Kadlec KE, Sanhueza P, Woodley-Remus D, Sellers EM. Fluoxetine differentially alters alcohol intake and other consummatory behaviors. Clin Pharmacol Ther 1990;47:490-498.
50. Gorelick DA, Paredes A. Effect of fluoxetine on alcohol consumption in male alcoholics. Alcohol Clin Exp Res. 1992;16 261-265.
51. Quitkin FM The importance of dose in prescribing antidepressants. Br J Psychiatry. 1985;147:593-597.
52. Stibler S Carbohydrate-deficient transferrin in serum a new marker of potentially harmful alcohol consumption reviewed. Clin Chem. 1991;37:2029-2037.
53. Reimherr FW, Wood DR, Byerley B, Brainard J, Grosser BI Characteristics of responders to fluoxetine. Psychopharm Bull 1987,3070-72.
54. Naranjo CA, Sellers EM, Lawrin MO Modulation of ethanol intake by serotonin uptake inhibitors. J Clin Psychiatry. 1986;47(suppl) 16-22